Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia Rheumatica

Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study

(2016) Valérie Devauchelle-Pensec et al.   ANNALS OF THE RHEUMATIC DISEASES

Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: a systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations for the management of polymyalgia rheumatica

(2015) Christian Dejaco et al.   ANNALS OF THE RHEUMATIC DISEASES

Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy

(2014) Shunsuke Mori et al.   CLINICAL RHEUMATOLOGY

Effective Control of Polymyalgia Rheumatica With Tocilizumab

(2013) Abdulrahman Al Rashidi et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Tocilizumab for polymyalgia rheumatica: Report of two cases and review of the literature

(2013) Pierluigi Macchioni et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

2012 Provisional classification criteria for polymyalgia rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative

(2012) Bhaskar Dasgupta et al.   ARTHRITIS AND RHEUMATISM

Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica

(2012) S. Unizony et al.   ARTHRITIS CARE & RESEARCH

Tocilizumab Ameliorates Clinical Symptoms in Polymyalgia Rheumatica

(2010) K. HAGIHARA et al.   JOURNAL OF RHEUMATOLOGY

Serum interleukin-6 receptor in polymyalgia rheumatica: A potential marker of relapse/recurrence risk

(2008) Lia Pulsatelli et al.   ARTHRITIS AND RHEUMATISM